Evoke Pharma discusses Q4 2024 financial performance

Evoke Pharma, Inc. held its Q4 2024 earnings call on March 13, 2025. The call featured key executives, including CEO Matt D’Onofrio and CFO Mark Kowieski, who discussed the company's financial performance and recent developments. The company has filed its annual report on Form 10-K with the SEC, which is available on its website. Participants were reminded that forward-looking statements made during the call are subject to risks and uncertainties. Evoke Pharma's press release and earnings report provide further details on its financial results and business outlook. The call concluded with an invitation for questions from participants.